Skip to content
Updated How AI-exposed are the skills employers are hiring for? See the data →

From the employer's careers site First seen 25 Oct 2026

Medical Director, Oncology Clinical Development - GI

GSK Hybrid senior full-time

Salary

$222,750 to $371,250 per year

Apply on GSK

Description

The Medical Director, Oncology Clinical Development - GI is the physician within the clinical programme team, bringing medical expertise, clinical judgement, and a patient-centred perspective to the design, conduct, and interpretation of clinical studies.

In this role, you will:

  • Serve as the physician within the clinical programme team, providing medical expertise across study design, conduct, safety oversight, and data interpretation
  • Lead medical monitoring activities for clinical studies, ensuring patient safety, clinical integrity, and compliance with the protocol and regulatory requirements
  • Interpret clinical and safety data from a physician perspective, generating insights that inform study-level and programme-level decisions
  • Partner with the Senior Scientist and cross-functional teams to ensure medical considerations are integrated into study execution and delivery
  • Contribute medical expertise to protocol development, ensuring clinical relevance, patient safety, and feasibility
  • Serve as a core member of the Clinical Matrix Team (CMT), providing the medical voice in study-level discussions and cross-functional decision-making
  • Engage with investigators and Key External Experts (KEEs) to support study conduct, scientific exchange, and external representation of the programme
  • Contribute to regulatory documents, Health Authority interactions, and scientific communications from a physician perspective

Detailed Responsibilities:

  • Medical Monitoring and Safety Oversight: Lead medical monitoring activities for assigned clinical studies, including real-time clinical decision-making on patient eligibility, protocol-related medical queries, and safety oversight
  • Study Design and Execution: Provide medical input into protocol development, ensuring clinical relevance, patient safety, and operational feasibility
  • Data Interpretation and Scientific Contribution: Interpret clinical data from a physician perspective, translating findings into insights on safety, efficacy, and patient impact
  • Regulatory and External Engagement: Contribute medical expertise to regulatory documents and Health Authority interactions
  • Cross-Functional Collaboration and Clinical Matrix Team: Serve as a core member of the Clinical Matrix Team (CMT), providing medical leadership within study execution

Basic Qualifications:

  • MD (or equivalent medical degree) with board certification or eligibility in oncology, haematology, or a related specialty
  • Clinical experience in oncology and/or relevant therapeutic areas, with direct exposure to clinical research or drug development
  • Demonstrated experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation
  • Strong working knowledge of clinical development processes, including GCP, ICH guidelines, and global regulatory frameworks

Preferred Qualifications:

  • Experience in pharmaceutical or biotechnology clinical development across Phase I–III GI oncology studies
  • Prior experience contributing to regulatory interactions (e.g., IND submissions, scientific advice, NDA/MAA filings)
  • Demonstrated experience engaging with Key External Experts (KEEs), investigators, and scientific collaborators in oncology

Skills

Required

  • Analytical Thinking
  • Clinical Data Interpretation
  • Clinical Development
  • Clinical Pharmacology
  • Clinical Trial Designs
  • Clinical Trials Monitoring
  • Digital Fluency
  • Drug Regulatory Affairs
  • Evidence Based Decision Making
  • Executive Presence
  • Hematology and Oncology
  • Learning Agility
  • Matrix Leadership
  • Real World Evidence (RWE)
  • Scientific Presentations

Nice to have

  • Experience in pharmaceutical or biotechnology clinical development across Phase I–III GI oncology studies
  • Prior experience contributing to regulatory interactions
  • Demonstrated experience engaging with Key External Experts (KEEs)
  • Track record of contributing to clinical publications
  • Deep understanding of oncology disease biology
Apply on GSK